Assessment of medical care provided to patients with obstructive lung diseases in the federal districts of the Russian Federation
- Authors: Linnik S.A.1,2, Avdeev S.N.3, Tumenko E.E.1,2, Shvachko S.A.1,2
-
Affiliations:
- N.A. Semashko National Research Institute of Public Health
- Scientific Medical Society “Medical Practice”
- I.M. Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 69, No 4 (2025)
- Pages: 342-349
- Section: HEALTH CARE ORGANIZATION
- Submitted: 18.03.2026
- URL: https://journals.eco-vector.com/0044-197X/article/view/704674
- DOI: https://doi.org/10.47470/0044-197X-2025-69-4-342-349
- EDN: https://elibrary.ru/iafnny
- ID: 704674
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
Introduction. Obstructive lung diseases have a significant impact on the country’s economy. The factors that influence on the level of medical care for these patients remain poorly understood. The influence of some factors of public health determinants on the mortality rate in patients from broncho-obstructive diseases has been studied.
Materials and methods. We calculated the correlation coefficient between specific factors of public health determinants, after which each pair of correlation coefficients was assigned a coefficient: for a correlation coefficient value of 0.9 or higher — 1; 0.70–0.89 — coefficient 0.9; 0.50–0.69 — coefficient 0.8; 0.30–0.49 — coefficient 0.7; less than 0.29 — 0.6. Then we calculated the total score obtained by multiplying standardized indicators of each studied factor by the coefficient, which calculation described above, for each federal district.
Results. A very strong inverse correlation was found between mortality and economic factors, the number of annual treatment courses, the smoking prevalence, as well as the amount of funds spent on drug provision. A strong inverse correlation was observed with the level of funds spent on preferential drug provision. The correlation with the frequency of use of fixed triple combinations of drugs and the sum of compulsory medical insurance funds spent on drug provision was moderate. The link with availability for pulmonologists was weak, while there was no connection with availability of general practitioners. Calculation of the total scores of the studied factors revealed a substantially higher value in St. Petersburg — 29.3. Moscow and the Northwestern Federal District (excluding St. Petersburg) had totals two or more times lower than just St. Petersburg alone. The lowest total score was in the North Caucasian Federal District.
Research limitations. The study is limited by the examined public health determinants.
Conclusion. An integrated assessment of the quality of medical care provided to patients with obstructive lung diseases based on an analysis of public health determinants can serve a tool for the healthcare management in the federal districts of the Russian Federation.
Materials and methods. We calculated the correlation coefficient between specific factors of public health determinants, after which each pair of correlation coefficients was assigned a coefficient: for a correlation coefficient value of 0.9 or higher — 1; 0.70–0.89 — coefficient 0.9; 0.50–0.69 — coefficient 0.8; 0.30–0.49 — coefficient 0.7; less than 0.29 — 0.6. Then we calculated the total score obtained by multiplying standardized indicators of each studied factor by the coefficient, which calculation described above, for each federal district.
Results. A very strong inverse correlation was found between mortality and economic factors, the number of annual treatment courses, the smoking prevalence, as well as the amount of funds spent on drug provision. A strong inverse correlation was observed with the level of funds spent on preferential drug provision. The correlation with the frequency of use of fixed triple combinations of drugs and the sum of compulsory medical insurance funds spent on drug provision was moderate. The link with availability for pulmonologists was weak, while there was no connection with availability of general practitioners. Calculation of the total scores of the studied factors revealed a substantially higher value in St. Petersburg — 29.3. Moscow and the Northwestern Federal District (excluding St. Petersburg) had totals two or more times lower than just St. Petersburg alone. The lowest total score was in the North Caucasian Federal District.
Research limitations. The study is limited by the examined public health determinants.
Conclusion. An integrated assessment of the quality of medical care provided to patients with obstructive lung diseases based on an analysis of public health determinants can serve a tool for the healthcare management in the federal districts of the Russian Federation.
About the authors
Sergey A. Linnik
N.A. Semashko National Research Institute of Public Health; Scientific Medical Society “Medical Practice”
Email: Linnik2001@mail.ru
ORCID iD: 0000-0002-0538-5400
DSc (Medicine), leading researcher, N.A. Semashko National Research Institute of Public Health, Moscow, 105064, Russian Federation; general manager, Scientific Medical Society “Medical Practice”, Moscow, 105064, Russian Federation
Sergey N. Avdeev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Email: serg_avdeev@list.ru
ORCID iD: 0000-0002-5999-2150
DSc (Medicine), Professor, Academician of RAS, Head, Pulmonology department, I.M. Sechenov First Moscow State Medical University (Sechenov University), chief freelance pulmonologist, Ministry of Health of Russian Federation, Moscow, 119048, Russian Federation
Elena E. Tumenko
N.A. Semashko National Research Institute of Public Health; Scientific Medical Society “Medical Practice”
Email: Tumenko@list.ru
ORCID iD: 0000-0001-5097-3722
director for the strategic development, Scientific Medical Society “Medical Practice”, Moscow, 117342, Russian Federation
Sergey A. Shvachko
N.A. Semashko National Research Institute of Public Health; Scientific Medical Society “Medical Practice”
Email: sashvachko@yandex.ru
ORCID iD: 0000-0002-9387-6479
director for marketing, Scientific Medical Society “Medical Practice”, Moscow, 117342, Russian Federation
References
Авдеев С.Н., Ненашева Н.М., Жуденков К.В., Петраковская В.А., Изюмова Г.В. Распространенность, заболеваемость, фенотипы и другие характеристики тяжелой бронхиальной астмы в Российской Федерации. Пульмонология. 2018; 28(3): 341–58. https://doi.org/10.18093/0869-0189-2018-28-3-341-358 https://elibrary.ru/xwcrrz Global Initiative for Asthma. 2018 GINA Report, Global Strategy for Asthma Management and Prevention. Доступно: https://ginasthma.org/wp-content/uploads/2023/04/GINA-Main-Report-V1.3-2018-WMSA.pdf Mannino D.M., Buist S. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370(9589): 765–73. https://doi.org/10.1016/s0140-6736(07)61380-4 Драпкина О.М., Концевая А.В., Муканеева Д.К., Смирнова М.И., Анциферова А.А., Лукьянов М.М. и др. Прогноз социально-экономического бремени хронической обструктивной болезни легких в Российской Федерации в 2022 году. Пульмонология. 2022; 32(4): 507–16. https://doi.org/10.18093/0869-0189-2022-32-4-507-516 https://elibrary.ru/mzwuqy Линник С.А., Авдеев С.Н., Туменко Е.Е. Влияние динамики стоимости лекарственных препаратов для лечения пациентов с бронхообструктивными заболеваниями на доступность лекарственного лечения в Российской Федерации. Менеджер здравоохранения. 2025; (1): 66–75. https://doi.org/10.21045/1811-0185-2025-1-66-75 https://elibrary.ru/ascbvx Тишутин А.А. Финансовые механизмы в системе здравоохранения и медицинского обслуживания. Проблемы социальной гигиены, здравоохранения и истории медицины. 2021; 29(5): 1179–85. https://doi.org/10.32687/0869-866X-2021-29-5-1179-1185 https://elibrary.ru/dizeqo Андреева О.В. Современные подходы к разработке финансовой политики и финансового механизма в здравоохранении. Научно-методический электронный журнал «Концепт». 2014; (Т20): 3771–5. https://elibrary.ru/sjfalb Яковлева И.В. Повышение эффективности финансирования системы здравоохранения. Инновационное развитие экономики. 2019; (5-1): 207–13. https://elibrary.ru/vybety Total pharmaceutical expenditure as % of total health expenditure. Доступно: https://gateway.euro.who.int/en/indicators/hfa_578-6770-total-pharmaceutical-expenditure-as-of-total-health-expenditure/#id=19673 Улумбекова Г.Э., Гиноян А.Б., Калашникова А.В., Альвианская Н.В. Финансирование здравоохранения в России (2021–2024 гг.). Факты и предложения. ОРГЗДРАВ: новости, мнения, обучение. Вестник ВШОУЗ. 2019; 5(4): 4–19. https://doi.org/10.24411/2411-8621-2019-14001 https://elibrary.ru/wxqqbn Римашевская Н.М., Мигранова Л.А., Молчанова Е.В. Факторы, влияющие на состояние здоровья населения России. Народонаселение. 2011; 51(1): 038–49. https://elibrary.ru/pkxgpf Еругина М.В., Кром И.Л., Шмеркевич А.Б., Дорогойкин Д.Л., Жужлова Н.Ю., Шигаев Н.Н. и др. Доступность медицинской помощи как облигатный социальный предиктор здоровья населения в России (обзор). Саратовский научно-медицинский журнал. 2016; 12(2): 101–5. https://elibrary.ru/wzxgrl Линник С.А. Информационные технологии управления лекарственным обеспечением пациентов со злокачественными новообразованиями: Автореф. дисс. … д-ра мед. наук. М.; 2023. Коссова Т.В. Экономические детерминанты смертности от сердечно-сосудистых заболеваний в регионах России. Вопросы статистики. 2023; 30(1): 42–51. https://doi.org/10.34023/2313-6383-2023-30-1-42-51 https://elibrary.ru/sugazg Самородская И.В., Семенов В.Ю., Бойцов С.А. Влияние медицинских и немедицинских факторов на смертность населения. Проблемы социальной гигиены, здравоохранения и истории медицины. 2018; 26(5): 260–5. https://doi.org/10.32687/0869-866X-2018-26-5-260-265 https://elibrary.ru/mimqct Балашова С.А., Захарчук А.Р., Сидоренко М.В. Оценка взаимосвязи уровня социально-экономического развития с уровнем смертности в регионах РФ. Вестник Российского университета дружбы народов. Серия: экономика. 2020; 28(1): 83–97. https://doi.org/10.22363/2313-2329-2020-28-1-83-97 https://elibrary.ru/wcdvpg Авдеев С.Н., Никитина Л.Ю., Мержоева З.М., Нуралиева Г.С., Гайнитдинова В.В., Джиоева О.Н. и др. Реалии и перспективы организации пульмонологической помощи пациентам с хронической обструктивной болезнью легких в Российской Федерации. РМЖ. 2024; (1): 2–6. https://elibrary.ru/hulvxy Комлева Н.Е., Трубецков А.Д., Данилов А.Н., Шевчук Л.М., Гадяцкий А.Ю. Медико-социальные аспекты качества жизни, связанного со здоровьем. Здоровье населения и среда обитания – ЗНиСО. 2016; (9): 13–4. https://elibrary.ru/wmdign Weaver S.R., Dai D., Stauber C., Luo R., Rothenberg R. The Urban Health Index: A Handbook for its Calculation and Use. Доступно: https://researchgate.net/publication/281494847_The_Urban_Health_Index_A_handbook_for_its_calculation_and_use Васильева Т.П., Ларионов А.В., Русских С.В., Зудин А.Б., Васюнина А.Е., Васильев М.Д. Расчет индекса общественного здоровья в регионах Российской Федерации. Здоровье населения и среда обитания – ЗНиСО. 2022; 30(12): 7–16. https://doi.org/10.35627/2219-5238/2022-30-12-7-16 https://elibrary.ru/dujcs
Supplementary files
